Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Editorial Volume 7 Issue 11

Urinary Biomarkers for Urological Cancer

MB Hiremath*

P. G. Department of Studies in Microbiology and Biotechnology, Karnatak University, Karnataka, India

*Corresponding Author: MB Hiremath, P. G. Department of Studies in Microbiology and Biotechnology, Karnatak University, Karnataka, India.

Received: September 22, 2023; Published: October 01, 2023

Urinary biomarkers are substances that can be measured in the urine to help diagnose, monitor, or predict the course of urological cancers, such as bladder cancer. Urinary biomarkers can be useful for detecting cancer early, assessing the risk of recurrence or progression, and evaluating the response to treatment. Urinary biomarkers can also reduce the need for invasive procedures, such as cystoscopy or biopsy, which can cause discomfort and complications for patients [1].


  1. Lotan Y and Roehrborn CG. “Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses”. Urology 1 (2003): 109-118.
  2. Shariat SF., et al. “Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder”. Journal of Urology5 (2005): 1518-1525.
  3. Sarosdy MF., et al. “Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer”. Journal of Urology4 (2002): 1950-1954.
  4. Mian C., et al. “Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract”. Journal of Urology4 (1999): 1486-1489.
  5. O’Sullivan P., et al. “A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria”. Journal of Urology3 (2012): 741-747.
  6. Reinert T., et al. “Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation”. PLoS One10 (2012): e46297.
  7. Nisman B., et al. “Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma”. Cancer4 (1998): 689-695.


Citation: MB Hiremath. “Urinary Biomarkers for Urological Cancer”.Acta Scientific Medical Sciences 7.11 (2023): 01-02.


Copyright: © 2023 MB Hiremath. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US